Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SRD5A2 protein | affects expression | 20106945
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of SRD5A2 mRNA | increases expression | 15056816
|
D013196 |
Dihydrotestosterone |
hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A2 mRNA] | decreases reaction|increases expression | 15056816
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SRD5A2 mRNA | affects expression | 16483693
|
C028895 |
androstane-3,17-diol glucuronide |
SRD5A2 gene SNP results in decreased abundance of androstane-3,17-diol glucuronide | decreases abundance | 17136762
|
C005961 |
bis(tri-n-butyltin)oxide |
bis(tri-n-butyltin)oxide results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of SRD5A2 mRNA | increases expression | 16938428
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SRD5A2 mRNA | decreases expression | 20106945
|
C020735 |
dibutyldichlorotin |
dibutyldichlorotin results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
D003633 |
Dichlorodiphenyl Dichloroethylene |
Dichlorodiphenyl Dichloroethylene results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
C108373 |
dutasteride |
dutasteride results in decreased expression of SRD5A2 mRNA | decreases expression | 16806904
|
D004958 |
Estradiol |
Estradiol results in decreased expression of SRD5A2 mRNA | decreases expression | 20106945
|
C033789 |
fenarimol |
fenarimol results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
D018120 |
Finasteride |
Finasteride results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
D005485 |
Flutamide |
Flutamide results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
C014290 |
hydroxyflutamide |
hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A2 mRNA] | decreases reaction|increases expression | 15056816
|
D008044 |
Linuron |
Linuron results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
D008777 |
Methyltestosterone |
Methyltestosterone results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
C032727 |
piperidine |
piperidine analog results in decreased activity of SRD5A2 protein | decreases activity | 10896124
|
C032727 |
piperidine |
piperidine analog results in decreased activity of SRD5A2 protein | decreases activity | 10896124
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SRD5A2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C025299 |
polyphenols |
polyphenols results in decreased expression of SRD5A2 mRNA | decreases expression | 16293270
|
C045362 |
prochloraz |
prochloraz results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SRD5A2 mRNA | increases expression | 11222880
|
C011559 |
tributyltin |
tributyltin results in decreased activity of SRD5A2 protein | decreases activity | 12231121
|
C030665 |
triphenyltin |
triphenyltin results in decreased activity of SRD5A2 protein | decreases activity | 17218080
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.68 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.39 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.96 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.06 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.33 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.33 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Dichlorodiphenyl Dichloroethylene |
4.63 | 16487989 |
MESH:D000505 |
Alopecia |
marker/mechanism |
|
| 17136762 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.80 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.25 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.25 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.62 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.65 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Dichlorodiphenyl Dichloroethylene |
2.08 | 15061365 |
MESH:D001943 |
Breast Neoplasms |
|
dutasteride |
2.08 | 16806904 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.08 | 19861407 16675129 17261762 12948864 18497071 17018787 17289903 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.08 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.29 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.66 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
2.95 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
2.95 | 16924424 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.27 | 16120746 18850075 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.19 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.19 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.34 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.34 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.03 | 12621046 15340226 16354765 8697196 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.65 | 16293270 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 20055451 15322242 10048152 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.35 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.63 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.27 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
6.10 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.10 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.10 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.63 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Dichlorodiphenyl Dichloroethylene |
5.09 | 16487989 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.03 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.03 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.73 | 15322242 16714409 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.87 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.87 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.89 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.04 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.04 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.29 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.92 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.92 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.05 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.42 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.24 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.43 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.25 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.18 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Dichlorodiphenyl Dichloroethylene |
4.87 | 16487989 |
MESH:D006529 |
Hepatomegaly |
|
fenarimol |
13.65 | 2387028 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.65 | 19772884 16221962 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.65 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.86 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.58 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.87 | 16959395 18606429 8697196 15340226 16354765 |
MESH:D017588 |
Hyperandrogenism |
|
Flutamide |
5.29 | 15356085 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
9.34 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
triphenyltin |
9.34 | 10522495 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.73 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.73 | 18850075 18670907 |
MESH:D015228 |
Hypertriglyceridemia |
|
triphenyltin |
5.80 | 10522495 |
MESH:D007246 |
Infertility |
|
triphenyltin |
5.86 | 15205045 |
MESH:D007248 |
Infertility, Male |
|
Dichlorodiphenyl Dichloroethylene |
4.17 | 17192596 12948891 |
MESH:D007249 |
Inflammation |
|
polyphenols |
4.86 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.86 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.83 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.83 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.27 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.61 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.61 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.81 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.81 | 15610895 |
MESH:D007896 |
Leishmaniasis |
|
fenarimol |
5.28 | 18372651 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Dichlorodiphenyl Dichloroethylene |
4.57 | 12745335 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.26 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.26 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.26 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.74 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
6.97 | 15890375 9163691 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
6.97 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
6.97 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.45 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.45 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.24 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.24 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.45 | 16891317 11408345 17203775 11807958 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.31 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.62 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.34 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.07 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.88 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.81 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.81 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.87 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.56 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.27 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.14 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.91 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.91 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.77 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.17 | 19401270 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.08 | 12520081 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Flutamide |
4.85 | 15356085 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.39 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.08 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.02 | 11118676 11399792 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.73 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17823934 18306354 16998812 17136762 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Finasteride |
3.10 | 12597149 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flutamide |
3.10 | 3169114 |
MESH:C535830 |
Pseudovaginal perineoscrotal hypospadias |
marker/mechanism |
|
| |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.17 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.30 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.67 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 16192470 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.08 | 17997062 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.73 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.51 | 19048282 |
MESH:D014564 |
Urogenital Abnormalities |
marker/mechanism |
|
| |
MESH:D014570 |
Urologic Diseases |
|
Dichlorodiphenyl Dichloroethylene |
5.57 | 16487989 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.81 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.42 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.08 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.27 | 17120751 |